Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness.

Abstract

Transfusion-related immunomodulation (TRIM) in the intensive care unit (ICU) is difficult to define and likely represents a complicated set of physiologic responses to transfusion, including both proinflammatory and immunosuppressive effects. Similarly, the immunologic response to critical illness in both adults and children is highly complex and is characterized by both acute inflammation and acquired immune suppression. How transfusion may contribute to or perpetuate these phenotypes in the ICU is poorly understood, despite the fact that transfusion is common in critically ill patients. Both hyperinflammation and severe immune suppression are associated with poor outcomes from critical illness, underscoring the need to understand potential immunologic consequences of blood product transfusion. In this review we outline the dynamic immunologic response to critical illness, provide clinical evidence in support of immunomodulatory effects of blood product transfusion, review preclinical and translational studies to date of TRIM, and provide insight into future research directions.

• Authors: Jennifer A Muszynski, Philip C Spinella, Jill M Cholette, Jason P Acker, Mark W Hall, Nicole P Juffermans, Daniel P Kelly, Neil Blumberg, Kathleen Nicol, Jennifer Liedel, Allan Doctor, Kenneth E Remy, Marisa Tucci, Jacques Lacroix, Philip J Norris, Pediatric Critical Care Blood Research Network (Blood Net)
• Journal: Transfusion (Transfusion) Vol. 57 Issue 1 Pg. 195-206 (01 2017) ISSN: 1537-2995 [Electronic] United States
• PMID: 27696473 (Publication Type: Journal Article, Review)
• Copyright: © 2016 AABB.

Topics

• Acute Disease
• Adolescent
• Adult
• Blood Component Transfusion
• Child
• Child, Preschool
• Critical Illness
• Female
• Humans
• Immunomodulation
• Infant
• Inflammation (etiology, immunology)
• Intensive Care Units
• Male